Cargando…
2168: Lower rates of influenza infection following 2 dose series of high-dose vaccination in plasma cell disorders: Results of a randomized, double-blind, placebo-controlled study
OBJECTIVES/SPECIFIC AIMS: (1) Evaluate safety of a novel influenza vaccination strategy in patients with plasma cell disorders. (2) Measure laboratory-confirmed influenza infection rates following a novel influenza vaccination strategy in patients with plasma cell disorders. (3) Evaluate clinical co...
Autores principales: | Branagan, Andrew, Duffy, Eamon, Parker, Terri, Seropian, Stuart, Foster, Connor, Zhang, Lin, Verma, Rakesh, Gan, Geliang, Zelterman, Daniel, Brandt, Debra, Kortmansky, Jeremy, Witt, David, Dhodapkar, Madhav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799516/ http://dx.doi.org/10.1017/cts.2017.118 |
Ejemplares similares
-
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
por: Branagan, Andrew R., et al.
Publicado: (2021) -
Complete Genome Sequence of Streptococcus gallolyticus Strain XH2168
por: Yang, Siyuan, et al.
Publicado: (2023) -
PB2168: P27: A NOVEL SUBSTRATE OF PDGFR
por: Giron, Carlos Miguel Castillo, et al.
Publicado: (2023) -
Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)
por: Beeh, Kai M, et al.
Publicado: (2018) -
A Phase I Dose‐Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low‐Grade or Intermediate‐Grade B‐Cell or T‐Cell Lymphoma
por: Foss, Francine Marie, et al.
Publicado: (2018)